| Bioactivity | KT5823, a selective the cGMP-dependent protein kinase (PKG) inhibitor with an Ki value of 0.23 μM, it also inhibits PKA and PKC with Ki values of 10 μM and 4 μM, respectively[1]. KT5823 is a staurosporine-related protein kinase inhibitor, increases thyroid-stimulating hormone-induced (Na+/I- symporter) NIS expression, and iodide uptake in thyroid cells[2]. KT5823 arrests cells after the G0/G1 boundary and causes increases in the levels of apoptotic DNA fragmentation[3]. | |||||||||
| Name | KT5823 | |||||||||
| CAS | 126643-37-6 | |||||||||
| Formula | C29H25N3O5 | |||||||||
| Molar Mass | 495.53 | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
KT5823
CAS: 126643-37-6 F: C29H25N3O5 W: 495.53
KT5823, a selective the cGMP-dependent protein kinase (PKG) inhibitor with an Ki value of 0.23 μM, it also inhibits PKA
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.